Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Eniola Odetunde/Axios

Seven out of 10 college students have experienced anxiety, 53% have experienced depression and 29% have considered dropping out since the pandemic began, according to a new Generation Lab/Axios poll.

The big picture: The end is in sight, but students are still in for a cold, isolated second semester.

Students this fall had to decide whether a college experience largely stripped of football games, learning in classrooms and partying was worthwhile.

  • Despite the challenges, more than two-thirds said that it was at least somewhat worth the tuition, but nearly a third said it wasn't worth it.
  • In a separate study, however, three-quarters of nearly 4,000 survey respondents pursuing a bachelor’s degree in the fall semester rated the quality of their education highly in a new report from Gallup and the Lumina Foundation.

The Generation Lab polling shows that campuses have proven to be a less safe location than back at home. 13% of students say they contracted the coronavirus — a clip nearly 3x the broader U.S. population.

  • Since the pandemic began, more than 397,000 infections have occurred at more than 1,800 colleges and universities, according to a N.Y. Times survey.
  • This includes more than 6,600 college athletes, coaches and staff members who have tested positive.

The state of play: The thousands of U.S. colleges had to come up with their own systems to reopen for testing and contact tracing regiments, which was largely inefficient and shaky even after the fall semester began.

  • Many students still returned to college towns, rented off-campus housing and attended crowded gatherings, despite online only class offerings this fall.

The bottom line: The incoming spring semester could see more of the same challenges in educating and keeping students safe with serial testing.

  • Still, a majority of college leaders are recognizing the growing concern about the stressors on students’ mental health, according to the American Council on Education.

Methodology: The poll was conducted Dec. 14-16 from a representative sample of 1,036 college students nationwide from 2-year and 4-year schools. The margin of error is +/- 3 percentage points.

  • Generation Lab’s polling is conducted using a demographically representative panel of college students from around the country. The surveys are administered digitally.

Go deeper

Jan 29, 2021 - Health

J&J says its one-shot vaccine is 66% effective against moderate to severe COVID

Photo: Thiago Prudêncio/SOPA Images/LightRocket via Getty Images

Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.

Between the lines: The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company.

Jan 29, 2021 - Health

NYC set to restart indoor dining in February, weddings in March

Outdoor dining in New York City in January. Photo: Alexi Rosenfeld/Getty Images

Gov. Andrew Cuomo announced Friday that if the current coronavirus positivity in New York City holds, indoor dining will reopen at 25% capacity on Feb. 14, one of the busiest dining days of the year.

Why it matters: The forced closure of indoor dining in December caused major backlash, as New York's struggling restaurant industry had already been hit hard by pandemic restrictions. Restaurants will still be required to close at 1o p.m.

Jan 29, 2021 - World

EU grants conditional approval of AstraZeneca vaccine

Photo: Sunil Ghosh/Hindustan Times via Getty Images

The European Commission on Friday granted conditional approval of the Oxford-AstraZeneca coronavirus vaccine for people 18 years and older.

Why it matters: This is the third vaccine to receive approval from the commission, coming hours after the Emergency Medicines Agency recommended its authorization.